Literature DB >> 10873780

In vitro processing of human immunodeficiency virus type 1 Gag virus-like particles.

Y Morikawa1, M Shibuya, T Goto, K Sano.   

Abstract

Human immunodeficiency virus (HIV) Gag proteins are assembled into virus particles and then cleaved by the virion-associated HIV protease. Concomitant with Gag processing, doughnut-like HIV particles (the immature form) are converted to particles containing condensed cores (the mature form). Here we describe the in vitro processing of immature HIV Gag virus-like particles (VLP) by exogenously added HIV protease. Following delipidization, sequential processing of immature VLP showed that the matrix (MA)/capsid (CA) junction was cleaved faster than the CA/nucleocapsid (NC) junction, an altered order of processing when compared with authentic processing. When the in vitro processed VLP were analyzed on density gradients, most of the MA, CA-p15 intermediate, and NC were detected as a highly multimeric form, equivalent to the unprocessed VLP. In contrast, CA was found as a monomer dissociated from the multimeric CA-p15 following cleavage of the CA/NC junction. Electron microscopy revealed that the in vitro processing was accompanied by conversion of the doughnut-like particles to particles containing condensed cores and spherical outer shells. The cores, however, lacked core shells, which are normally observed for authentic HIV, suggesting that the in vitro processing of immature VLP failed to produce core shells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873780     DOI: 10.1006/viro.2000.0370

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

1.  PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing.

Authors:  F Li; R Goila-Gaur; K Salzwedel; N R Kilgore; M Reddick; C Matallana; A Castillo; D Zoumplis; D E Martin; J M Orenstein; G P Allaway; E O Freed; C T Wild
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-22       Impact factor: 11.205

2.  Atomic force microscopy investigation of human immunodeficiency virus (HIV) and HIV-infected lymphocytes.

Authors:  Y G Kuznetsov; J G Victoria; W E Robinson; A McPherson
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

3.  Stability studies of HIV-1 Pr55gag virus-like particles made in insect cells after storage in various formulation media.

Authors:  Alisson Lynch; Ann E Meyers; Anna-Lise Williamson; Edward P Rybicki
Journal:  Virol J       Date:  2012-09-18       Impact factor: 4.099

4.  Characterization of the invariable residue 51 mutations of human immunodeficiency virus type 1 capsid protein on in vitro CA assembly and infectivity.

Authors:  Samir Abdurahman; Masoud Youssefi; Stefan Höglund; Anders Vahlne
Journal:  Retrovirology       Date:  2007-09-28       Impact factor: 4.602

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.